On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Understanding the Obese Patient
May 26th 2015Obesity rates have climbed nearly 50 percent since 1997, with as much as 30 percent of the population classified as obese. There is strong belief within the health care industry that obesity should be treated as a primary medical condition, with physicians playing a major role. Evidence suggests that patients are more likely to lose weight when they are advised by their primary care physicians to do so.
Wide Variability in Medication Adherence among Patients with Atrial Fibrillation
Research indicates that, despite the relative simplicity of dabigatran regimens, physicians and pharmacists must follow up with patients repeatedly to maximize the chances they'll adhere to prescriptions.
One Step Closer to Ending Cancer Pain
May 26th 2015University of Toronto researchers have found a novel role for a cell membrane-anchored mediator in cancer pain. They suggest that the serine protease TMPRSS2-a gene previously shown to play a key role in some of the most aggressive forms of androgen-fuelled cancers-appears to be the trigger behind the most severe forms of cancer pain.
COPD Treatment Inhalation Spray Approved
Boehringer Ingelheim announced Tuesday the US Food and Drug Administration (FDA) approved once-daily Stiolto Respimat (tiotropium bromide and olodaterol) Inhalation Spray to treat airflow obstruction in patients suffering from chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
‘Pain Gene' Identified Through Those Who Can't Feel Physical Pain
May 26th 2015People with a rare inherited condition known as "congenial insensitivity to pain" (CIP), which makes it impossible for them to feel pain, may hold the answer to providing pain relief for patients suffering with chronic pain.
GLP-1 Receptor Agonists and Thyroid Cancer: Differentiating Cancer Type
May 22nd 2015GLP-1 receptor antagonists have been associated with thyroid cancer in rodents, and in fact carry a boxed warning about the potential for cancer in humans. This leads many clinicians to ask if they should be concerned about using these drugs in patients who have or develop specific types of thyroid cancer
Diabetes Drug Addresses Inflammation in HIV Patients
May 22nd 2015Sitagliptin appears to have beneficial systemic and adipose anti-inflammatory effects in combination antiretroviral therapy-treated HIV-positive adults with impaired glucose tolerance. The drug may prevent cardiovascular problems by reducing inflammation linked to heart disease and stroke in this patient population.
Antipsychotics Safe for Pregnant Women
May 21st 2015The results of the largest study of its kind to date indicate that new antipsychotic medications-including quetiapine, olanzapine, and risperidone-do not appear to put women at additional risk of developing gestational diabetes, hypertensive disorders, or major blood clots that obstruct circulation, all conditions that often develop during pregnancy or with the use of older antipsychotic medications.
CDC: Why Strong Swimmers Drowned
Fatal drownings happen even in strong, healthy swimmers in lifeguarded pools. A New York City health department investigation points to an under-reported cause: deliberate breath-holding as part of informal contests or self-imposed training regimens.
FDA Okays Hep-C Investigational Combo for Post-Transplant Patients
The FDA says the investigational drug combination of daclatasvir (Daklinza/ Bristol-Myers Squibb) and sofosbuvir (Sovaldi/Gilead ) may now be given to patients who have hepatitis C infections with either advanced cirrhosis or infections that have come back after patients received a liver transplant.
Longer Lasting Version of Schizophrenia Drug Approved
The US Food and Drug Administration today approved 3-month paliperidone palmitate (Invega Trinza/Janssen) a longer-lasting version of Janssen's paliperidone palmitate product marketed as Invega Sustenna, a treatment that works for only 1 month per injection.
Shocking Figures on Misdiagnoses and Incorrect Antibiotic Prescriptions
May 18th 2015Antibiotic resistance is a worldwide threat with potentially disastrous consequences. In the wake of a recent report claiming Salmonella is becoming less sensitive to medication, a new study shows how misdiagnoses are contributing to the growing problem.
Hysterectomy: Operative Time Matters
May 18th 2015Historically, surgical times were tracked to help operating suite managers schedule operating rooms. For the last 25 years or so, quality managers have watched surgical times with respect to patient outcomes. They've come to a growing realization that faster is not always better and slower may not represent careful, deliberate technique.
CDC Alert: Lakes Harbor Norovirus
Cruise ships are not the only place where vacationers can get the dreaded norovirus. A US Centers for Disease Control and Prevention report today documents an outbreak in a recreational lake in Oregon and warns that swimming in lakes can be hazardous.